Skip to content

AUTO-ACUSAR - Effects of Acupuncture on the Autonomic Nervous System in Seasonal Allergic Rhinitis Patients

Acupuncture in Seasonal Allergic Rhinitis- Effects on the Autonomic Nervous System (AUTO-ACUSAR)- an Explorative Substudy of ACUSAR

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01271595
Acronym
AUTO-ACUSAR
Enrollment
60
Registered
2011-01-07
Start date
2009-08-31
Completion date
2011-05-31
Last updated
2018-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Seasonal Allergic Rhinitis

Keywords

acupuncture, autonomic nervous system, seasonal allergic rhinitis

Brief summary

There is inconclusive evidence whether acupuncture treatment is effective in the treatment of seasonal allergic rhinitis (SAR). Furthermore, the underlying mechanisms of acupuncture in SAR are only poorly understood. It was hypothesised that the therapeutic mechanism of acupuncture is related to changes in autonomic function. AUTO-ACUSAR is a sub-study of the DFG-funded three-arm randomized controlled trial ACUSAR trial investigating the efficacy of acupuncture vs. sham acupuncture vs. rescue medication in SAR. The aim of AUTO-ACUSAR was to investigate short and long-term effects of acupuncture vs. sham acupuncture on autonomic function in a sub-group of ACUSAR patients. Baseline values were compared to data from matched healthy controls.

Detailed description

In AUTO-ACUSAR a subsample of ACUSAR patients from acupuncture or sham acupuncture groups were included. Tests of autonomic functions included measurement of heart rate variability during paced breathing, blood pressure, heart rate and salivary alpha amylase response to a cold pressure test (CPT) and cortisol awakening response before the first and the last of twelve treatment sessions. Healthy matched controls underwent the same measurement once only

Interventions

OTHERsham acupuncture

12 sessions of sham acupuncture over 8 weeks

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
16 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Female or male patients (aged 16-45 years) with seasonal allergic rhinitis, clinically positive and test positive (skin-prick test and/or RAST) to grass and birch pollen * Patients with \>2 years of moderate to severe SAR * Positive skin-prick test and/or RAST (at least class 2) results * Visual analogue scale \>40mm and \<80 mm for SAR symptoms during the past year * Patients must be able to complete a diary for self-evaluation of symptoms and recording use of anti-symptomatic medication * Use of, or indication for, oral antihistamines as anti-allergic medication * Written informed consent

Exclusion criteria

* Perennial SAR or other types of chronic rhinitis * Allergic asthma and/or moderate to severe atopic dermatitis * Active tuberculosis * Auto-immune disorders * Severe chronic inflammatory diseases * History of anaphylactic reactions * Hypersensitivity to Rescue medication or related drugs used in study related drugs * Specific immunotherapy \>3 years * Simultaneous participation in other clinical trials * Serious acute or chronic organic disease or mental disorder * Pregnancy or breast feeding * Allergy desensitisation therapy (current, during the past two years, or planned in the next two years) * Blood coagulation disorder and/or current use of anticoagulants * Previous acupuncture treatment for SAR * Any Complementary and alternative medicine treatment at the moment, in the last three months or planned in the next two years * intake of Beta-Blocker Medication * use of pacemaker

Design outcomes

Primary

MeasureTime frameDescription
Heart Rate Variability8 weeksRMSSD, LF, HF, HR, blood pressure

Secondary

MeasureTime frameDescription
Salivary Amylase and Cortisol, Cortisol Awakening Response (CAR)8 weeksMeasurements were taken during the experimental setting 3 times , CAR by the patients the day before first and last acupuncture

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026